Bayer has started a phase 3 trial of its intrauterine contraceptive Mirena in an endometrial condition that can lead to ...

Please provide your email address to receive an email when new articles are posted on . Age, nulliparity, polyps and shorter sampling intervals may predict endometrial hyperplasia and cancer. Risk ...

Bayer initiates phase III study SUNFLOWER with long-acting reversible intrauterine system for treatment of nonatypical endometrial hyperplasia: Berlin Wednesday, December 3, 2025, ...

Bayer announced today the start of its Phase III study SUNFLOWER, an investigational study evaluating the efficacy and safety ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Bayer AG is launching a new clinical ...

Please provide your email address to receive an email when new articles are posted on . Conjugated estrogen/bazedoxifene users had higher endometrial cancer and endometrial hyperplasia rates vs.

Endometrial cancer is a type of cancer in the lining of the uterus (also known as the endometrium). It is the most common type of gynecologic cancer in women. There are many treatments for endometrial ...

Uterine cancer is the fourth most common cancer among women and the most common cancer of a woman's reproductive system. There are two major types of uterine cancer: Adenocarcinoma of the endometrium: ...

What Is Recurrent Endometrial Cancer? Endometrial cancer is a type of cancer that starts in the lining of the uterus, called the endometrium. It's the most common form of gynecologic cancer in the ...

Berlin: Bayer has announced the clinical Phase III study SUNFLOWER with its 52mg levonorgestrel-releasing intrauterine system ...